UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 4 | April 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 8 Issue 4
April-2021
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2104306


Registration ID:
307508

Page Number

787-800

Share This Article


Jetir RMS

Title

A Clinical Study of Majoon Ushba and Marhame Safeda Kafoori in the Management of Daus Sadaf (Psoriasis)

Abstract

Psoriasis is a Greek word derived from “so-ri-a-sis” means itching while Daus Sadaf is an Arabic word derived from “Da” means “disease” and “Al-Sadaf” means “molluscum shells” (seep). It was considered as Taqash’shur-e-Jild (Ichthyosis) by Unani physicians. Aims and Objectives: To assess the efficacy of Majoon Ushba and Marhame Safeda-Kafoori in the management of psoriasis. Material & Methods: All the patients were given Majoon Ushba 5 gm twice daily for systemic administration and Marhame Safeda Kafoori for local application twice a day. The duration of therapy was 90 days with 6 visits at every 15 days. The assessment of efficacy was based on subjective and objective parameters. In subjective parameters symptoms included Itching, Erythema, Scaling and Induration etc., while the objective parameters included Psoriasis Area Severity Index (PASI) scale and Pictures of lesions. The data of clinical and laboratory findings were analyzed by using Paired “t” test. Result: The mean value of PASI score at the time of commencement of study was 24.15±14.44 which decreased significantly to 4.73±4.73 (p<0,001) indicating a significant antipsoriatic effect produced by the test drug. Conclusion: Based on the findings it can be concluded that Unani drugs, Majoon Ushba and Marham-e-Safeda Kafoori possess significant antipsoriatic effect and can be used in the management of Psoriasis.

Key Words

Daus Sadaf, MajoonUshba, Marhame Safeda-Kafoori, PASI, Psoriasis, Unani Medicine.

Cite This Article

"A Clinical Study of Majoon Ushba and Marhame Safeda Kafoori in the Management of Daus Sadaf (Psoriasis)", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.8, Issue 4, page no.787-800, April-2021, Available :http://www.jetir.org/papers/JETIR2104306.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"A Clinical Study of Majoon Ushba and Marhame Safeda Kafoori in the Management of Daus Sadaf (Psoriasis)", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.8, Issue 4, page no. pp787-800, April-2021, Available at : http://www.jetir.org/papers/JETIR2104306.pdf

Publication Details

Published Paper ID: JETIR2104306
Registration ID: 307508
Published In: Volume 8 | Issue 4 | Year April-2021
DOI (Digital Object Identifier):
Page No: 787-800
Country: LUCKNOW, UP, India .
Area: Medical Science
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000729

Print This Page

Current Call For Paper

Jetir RMS